Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

Study identifier:AMP-110-02

ClinicalTrials.gov identifier:NCT02277574

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Multi-Dose, Placebo-Controlled, Study of the Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects with Rheumatoid Arthritis

Medical condition

Rheumatoid Arthritis

Phase

Phase 1

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

29

Study type

Interventional

Age

18 Years - 75 Years

Date

Study Start Date: 01 Jun 2014
Primary Completion Date: 01 Jan 2015
Study Completion Date: 01 Jul 2015

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2016 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

Daiichi Sankyo Co., Ltd.

Inclusion and exclusion criteria